Breaking News
April 22, 2018 - New Drug Combo Ups Survival in HER2/neu Uterine Serous Cancer
April 22, 2018 - Researchers chart a new way to look at concussion
April 22, 2018 - Every parent needs to know fundamental red flags for autism
April 22, 2018 - Anatotemp expands anatomic dental implant healing abutments with 4Side anti-rotational connection
April 22, 2018 - Gene Twist Can Make Your Blood Pressure Spike From Salt
April 22, 2018 - Study suggests failed osteoarthritis drug could help treat opioid addiction
April 22, 2018 - More Americans aware of growing problem of opioid addiction
April 22, 2018 - KHN’s ‘What the Health?’ Nothing in health care ever goes away
April 22, 2018 - BGS to promote high-quality sterilization services at Health GB in Manchester
April 22, 2018 - New integrated POC tool detects biomarkers of heart failure rapidly and precisely
April 22, 2018 - Direct electrical current can be delivered to nerves for blocking pain signals
April 22, 2018 - Newly Published Phase 2 Study Found Esketamine Demonstrated Significantly Rapid Improvements in Depressive Symptoms and Suicidality
April 22, 2018 - Healthy red blood cells owe their shape to muscle-like structures
April 22, 2018 - Researchers present case study of management of rheumatic mitral regurgitation in woman contemplating pregnancy
April 22, 2018 - New black Porvair Krystal UV Quartz microplates for Circular Dichroism measurements
April 22, 2018 - Advanced flow chemistry modules enhance control of nanoprecipitation
April 22, 2018 - Look! Down in the petri dish! It’s a superplatelet!
April 22, 2018 - Research reveals why people with tetraplegia more likely to suffer from sleep apnea
April 21, 2018 - New non-invasive nerve stimulation may offer relief for people with hand tremor
April 21, 2018 - Smartphone App May Up Medication Adherence in HTN
April 21, 2018 - Western diet depletes artery-protecting immune cells
April 21, 2018 - Excelitas Technologies launches new powerful LED light source for fluorescence microscopy
April 21, 2018 - Academia and high tech companies join forces to increase production capacity for microfluidic systems
April 21, 2018 - Developing cooking skills as young adult may have long-term health benefits
April 21, 2018 - Study compares survival outcomes of different drugs for type 2 diabetes
April 21, 2018 - More Than 40 Percent of Americans Breathe Dirty Air: Report
April 21, 2018 - Obstructive sleep apnea – Genetics Home Reference
April 21, 2018 - More evidence shows exposure to traffic and outdoor air pollution increases risk of asthma
April 21, 2018 - Novel gold nanoparticle technology could guide cancer treatment in real-time
April 21, 2018 - News coverage of Ebola impacted public’s perception on disease and survivors
April 21, 2018 - S.Africa’s DIY battle against HIV
April 21, 2018 - Children with autism have gastrointestinal and immune system deregulation, research finds
April 21, 2018 - Human brain processes sight and sound in the same way, shows study
April 21, 2018 - Evolutionary history of tumor helps predict severity of prostate cancer
April 21, 2018 - Pepper plant metabolizes antibiotic in personal care products
April 21, 2018 - Tradeshow Talks with Integra
April 21, 2018 - EPFL becomes part of Chan Zuckerberg’s project to develop Human Cell Atlas
April 21, 2018 - Pfizer Announces Positive Topline Results From Phase 3 ATTR-ACT Study Of Tafamidis In Patients With Transthyretin Cardiomyopathy
April 21, 2018 - Breaking through the HIV vaccine ‘logjam’
April 21, 2018 - IntelliCyt introduces new QSol buffer to enable robust, consistent sampling
April 21, 2018 - Scientists publish comprehensive lineage tree of whole adult animal in Science journal
April 21, 2018 - Innovative method based on FluidFM technology could revolutionize biological research
April 21, 2018 - Americans world’s biggest TV addicts, watching four hours a day
April 21, 2018 - Investigational drug may help increase protein levels in babies with spinal muscular atrophy
April 21, 2018 - Study shows distinctions between age groups in predicting and responding to stress at home
April 21, 2018 - Aziyo Biologics, BIOTRONIK enter into US co-distribution agreement
April 21, 2018 - Opiate Use Linked to Early Mortality in IBD Patients
April 21, 2018 - Online ads help pregnant smokers quit
April 21, 2018 - Opioid pain medications may not be safe for hemodialysis patients
April 21, 2018 - Rare variants in non-coding DNA inherited from parents heighten autism risk
April 21, 2018 - A needleless glucose monitor for diabetes patients
April 21, 2018 - BD introduces new informatics and automation solutions for clinical laboratories
April 21, 2018 - Turn Chores Into a Fitness Routine
April 21, 2018 - DNA methylation plays key role in stem cell differentiation
April 21, 2018 - Scientists find link between soil metals and cancer mortality
April 21, 2018 - Experts discuss implications of low calcium intake in global population
April 21, 2018 - GNA Biosolutions to display Pharos V8 Laser PCR instrument at Analytica trade fair
April 21, 2018 - People with vitamin D deficiency may be at greater risk of diabetes
April 21, 2018 - Study findings could open new possibilities for treating cancer with adenovirus
April 21, 2018 - People who use medical marijuana have higher rates of prescription drug use, study finds
April 21, 2018 - Study debunks ‘myth’ that strenuous exercise dampens immunity
April 21, 2018 - FDA approves marijuana based medication for epilepsy treatment
April 21, 2018 - Researchers find novel genes for longevity in mammals
April 21, 2018 - GNA Biosolutions and project partners launch new research project to develop TB diagnostic platform for POC applications
April 21, 2018 - $2 million funding boosts progress of UAB biomedical startup
April 21, 2018 - Scientists identify gene responsible for evolution of recombination rates
April 21, 2018 - UConn researchers develop new composite for healing broken load-bearing bones
April 21, 2018 - Study examines how higher-order gene combinations help maintain normal cell physiology
April 21, 2018 - Study challenges use of whole-brain radiation for small-cell lung cancer patients with brain metastases
April 21, 2018 - Researchers discover blood biomarkers that may help detect, confirm mild traumatic brain injury
April 21, 2018 - People who become physically active after heart attack more likely to live longer, shows research
April 21, 2018 - CPRIT awards $2 million grant to push forward breast cancer research in West Texas
April 21, 2018 - Unhealthy diet damages the development of immature fat cells, study shows
April 21, 2018 - Consumption of protein supplements with meals may provide better weight control
April 21, 2018 - 4 Types of Foods to Help Boost Your Memory
April 21, 2018 - How did gonorrhea become a drug-resistant superbug?
April 21, 2018 - DePuy Synthes announces clinical results related to use of CORAIL Hip System Femoral Stems
April 21, 2018 - New initiative launched to support goals of Human Cell Atlas
April 20, 2018 - Teen patient gets a new lease on life
April 20, 2018 - Cancer Australia launches new framework to improve outcomes for lung cancer patients

FDA Approves Rydapt (midostaurin) for FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis

image_pdfDownload PDFimage_print

FDA Approves Rydapt (midostaurin) for FLT3-Mutated Acute Myeloid Leukemia and Systemic Mastocytosis

April 28, 2017 — The U.S. Meals and Drug Management lately authorized Rydapt (midostaurin) for the remedy of grownup sufferers with newly identified acute myeloid leukemia (AML) who’ve a selected genetic mutation referred to as FLT3, together with chemotherapy. The drug is authorized to be used with a spouse diagnostic, the LeukoStrat CDx FLT3 Mutation Assay, which is used to locate the FLT3 mutation in sufferers with AML.

AML is a unexpectedly progressing most cancers that bureaucracy within the bone marrow and ends up in an larger selection of white blood cells within the bloodstream. The Nationwide Most cancers Institute estimated that roughly 19,930 other people can be identified with AML in 2016 and 10,430 had been projected to die of the illness.

“Rydapt is the primary centered remedy to regard sufferers with AML, together with chemotherapy,” stated Richard Pazdur, M.D., appearing director of the Place of business of Hematology and Oncology Merchandise within the FDA’s Heart for Drug Analysis and Analysis and director of the FDA’s Oncology Heart of Excellence. “The facility to locate the gene mutation with a diagnostic take a look at manner medical doctors can establish particular sufferers who might have the benefit of this remedy.”

Rydapt is a kinase inhibitor that works by way of blockading a number of enzymes that advertise mobile expansion. If the FLT3 mutation is detected in blood or bone marrow samples the usage of the LeukoStrat CDx FLT3 Mutation Assay, the affected person is also eligible for remedy with Rydapt together with chemotherapy.

The security and efficacy of Rydapt for sufferers with AML had been studied in a randomized trial of 717 sufferers who had no longer been handled in the past for AML. Within the trial, sufferers who won Rydapt together with chemotherapy lived longer than sufferers who won chemotherapy by myself, even if a selected median survival price may just no longer be reliably estimated. As well as, sufferers who won Rydapt together with chemotherapy within the trial went longer (median eight.2 months) with out sure headaches (failure to reach whole remission inside 60 days of beginning remedy, development of leukemia or loss of life) than sufferers who won chemotherapy by myself (median 3 months).

Commonplace uncomfortable side effects of Rydapt in sufferers with AML come with low ranges of white blood cells with fever (febrile neutropenia), nausea, irritation of the mucous membranes (mucositis), vomiting, headache, spots at the pores and skin because of bleeding (petechiae), musculoskeletal ache, nosebleeds (epistaxis), device-related an infection, top blood sugar (hyperglycemia) and higher respiration tract an infection. Rydapt must no longer be utilized in sufferers with allergy to midostaurin or different elements in Rydapt. Girls who’re pregnant or breastfeeding must no longer take Rydapt as a result of it will reason hurt to a creating fetus or a new child child. Sufferers who revel in indicators or signs of lung injury (pulmonary toxicity) must forestall the usage of Rydapt.

Rydapt used to be additionally authorized lately for adults with sure varieties of uncommon blood problems (competitive systemic mastocytosis, systemic mastocytosis with related hematological neoplasm or mast mobile leukemia). Commonplace uncomfortable side effects of Rydapt in those sufferers come with nausea, vomiting, diarrhea, swelling (edema), musculoskeletal ache, belly ache, fatigue, higher respiration tract an infection, constipation, fever, headache and shortness of breath.

The FDA granted this utility Precedence Evaluation, Rapid Monitor (for the mastocytosis indication) and Step forward Treatment (for the AML indication) designations.

The FDA granted the approval of Rydapt to Novartis Prescribed drugs Company. The FDA granted the approval of the LeukoStrat CDx FLT3 Mutation Assay to Invivoscribe Applied sciences Inc.

Supply: FDA

Posted: April 2017

Rydapt (midostaurin) FDA Approval Historical past

View feedback

Tagged with:

About author

Related Articles